AM-Pharma B.V.

Hypophosphatasia and Bone Mineral Metabolism

Research activity includes adult hypophosphatasia, with attention to inorganic pyrophosphate and pyridoxal 5’-phosphate as biochemical markers linked to the disorder.

  • Enzyme replacement in hypophosphatasia
  • Biomarker changes in mineral metabolism
  • Adult metabolic bone disease

The sponsor’s work in this area centers on ilofotase alfa in the context of alkaline phosphatase deficiency.

Renal Protection and Kidney Function

Clinical interest extends to renal damage associated with open heart surgery, with evaluation of interventions aimed at preserving renal function.

  • Acute kidney injury prevention
  • Postoperative renal impairment
  • Cardiac surgery–related kidney risk

This area reflects an interest in protecting the kidneys in the setting of major cardiothoracic surgery.

Cardiothoracic Surgery and Perioperative Care

The sponsor funds research connected to cardiac surgery, especially clinical questions involving postoperative organ protection and recovery.

  • Open heart surgery
  • Perioperative organ protection
  • Surgical complication prevention

These studies place emphasis on outcomes relevant to patients undergoing complex heart procedures.

Biochemical and Translational Medicine

Trial activity includes measurement of circulating biochemical signals associated with metabolic and renal conditions, supporting therapeutic development around targeted biologic intervention.

  • Circulating biomarkers
  • Metabolic disease monitoring
  • Targeted biologic therapy

The research portfolio connects laboratory markers with clinically relevant endpoints in rare disease and surgical settings.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of ilofotase alfa effects on biomarkers in adults with hypophosphatasia

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study on Ilofotase Alfa to Prevent Kidney Damage in Patients Undergoing Open Heart Surgery

    Not recruiting

    Investigated drugs:
    Belgium Germany The Netherlands